These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

716 related items for PubMed ID: 25505238

  • 1. Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
    Heijnsdijk EA, de Carvalho TM, Auvinen A, Zappa M, Nelen V, Kwiatkowski M, Villers A, Páez A, Moss SM, Tammela TL, Recker F, Denis L, Carlsson SV, Wever EM, Bangma CH, Schröder FH, Roobol MJ, Hugosson J, de Koning HJ.
    J Natl Cancer Inst; 2015 Jan; 107(1):366. PubMed ID: 25505238
    [Abstract] [Full Text] [Related]

  • 2. Re: Cost-Effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data.
    Taneja SS.
    J Urol; 2015 Jul; 194(1):113-4. PubMed ID: 26088223
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies.
    Roth JA, Gulati R, Gore JL, Cooperberg MR, Etzioni R.
    JAMA Oncol; 2016 Jul 01; 2(7):890-8. PubMed ID: 27010943
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data.
    Booth N, Rissanen P, Tammela TLJ, Kujala P, Stenman UH, Taari K, Talala K, Auvinen A.
    PLoS One; 2019 Jul 01; 14(11):e0224479. PubMed ID: 31689326
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.
    Gulati R, Gore JL, Etzioni R.
    Ann Intern Med; 2013 Feb 05; 158(3):145-53. PubMed ID: 23381039
    [Abstract] [Full Text] [Related]

  • 9. Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada.
    Pataky R, Gulati R, Etzioni R, Black P, Chi KN, Coldman AJ, Pickles T, Tyldesley S, Peacock S.
    Int J Cancer; 2014 Aug 15; 135(4):939-47. PubMed ID: 24443367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios.
    Getaneh AM, Heijnsdijk EAM, Roobol MJ, de Koning HJ.
    Cancer Med; 2020 Oct 15; 9(20):7742-7750. PubMed ID: 32813910
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life.
    Hogenhout R, Remmers S, van Slooten-Midderigh ME, de Vos II, Roobol MJ, ERSPC Rotterdam Study GroupDepartment of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands..
    Eur Urol Oncol; 2024 Aug 15; 7(4):713-720. PubMed ID: 37690917
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
    Tawfik A.
    Ont Health Technol Assess Ser; 2015 Aug 15; 15(11):1-37. PubMed ID: 26366237
    [Abstract] [Full Text] [Related]

  • 18.
    Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.
    ; 2018 05 15. PubMed ID: 30085502
    [Abstract] [Full Text] [Related]

  • 19. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis.
    Gulati R, Jiao B, Al-Faouri R, Sharma V, Kaul S, Fleishman A, Wymer K, Boorjian SA, Olumi AF, Etzioni R, Gershman B.
    Ann Intern Med; 2024 Jul 15; 177(7):871-881. PubMed ID: 38830219
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.